Very late-onset of inflammatory bowel disease. A case report
DOI:
https://doi.org/10.12775/JEHS.2022.12.02.017Keywords
inflammatory bowel disease (IBD), gastrointestinal bleeding, ulcerative colitis (UC), Crohn’s disease (CD), elderly patientsAbstract
Introduction
Inflammatory bowel disease (IBD) in most cases is classified into Crohn’s disease (CD) or ulcerative colitis (UC). It appears in 25-35 years of age and the second peak is after fifties. It is very rare to recognize it in the elderly.
Case presentation
We present a case of a 79-year-old female patient who was admitted to the Chair and Department of Gastroenterology with Endoscopic Unit at the Medical University of Lublin in December 2018 with an acute lower gastrointestinal hemorrhage and dyselectrolytemia. Additionally, she suffered from atrial fibrillation. She has been treated with an anticoagulant therapy and has been receiving dabigatran for many years. After 16 days of diagnostic research and intensive treatment the patient was discharged home with no previous symptoms. After the next 12 days at home our patient returned to the hospital with recurrent gastrointestinal bleeding, abdominal pain and after fainting episode. Digital rectal exam was positive and laboratory test showed anemia again. Colonoscopic findings on admission showed proximally to the splenic flexure blood signs, on Bauhin’s valve a flat ulcer. The histopathological report confirmed the inflammatory bowel disease. After diagnosis of IBD, an effective treatment with mesalazine and prednisone was started.
Conclusions
Despite the newest clinical trials are more and more common in Crohn’s disease or ulcerative colitis, the elderly patients are mostly excluded from them because of the other accompanying diseases and their burdensome side effects. Choosing the right therapy becomes the main problem in these patients after setting a proper diagnosis which can take years and many unnecessary hospitalizations.
References
Dorreen A, Heisler C, Jones J Treatment of Inflammatory Bowel Disease in the Older Patient. Inflamm Bowel Dis. 2018 May 18;24(6):1155-1166. doi: 10.1093/ibd/izy023.
Butter M, Weiler S, Biedermann L Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people. Maturitas. 2018 Apr;110:71-78. doi: 10.1016/j.maturitas.2018.01.015. Epub 2018 Jan 31.
Wei-ChenLin, Ming-JenChen, Cheng-HsinChu, Tsang-EnWang, Horng-YuanWang Ulcerative Colitis in Elderly People: An Emerging Issue; 30 May 2018 International Journal of Gerontology.
van Walree IC, van Tuyl SA, Hamaker ME Late-onset inflammatory bowel disease in the very elderly. Neth J Med. 2015 Jan;73(1):4-9.
Picco MF, Cangemi JR Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2009 Sep;38(3):447-62. doi: 10.1016/j.gtc.2009.06.006.
Herszényi L, Barabás L, Miheller P Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis. 2015;33(1):52-7. doi: 10.1159/000368447. Epub 2014 Dec 17.
Brackmann S, Andersen SN, Aamodt G Two distinct groups of colorectal cancer in inflammatory bowel disease. Inflamm Bowel Dis. 2009 Jan;15(1):9-16. doi: 10.1002/ibd.20542.
Fries W, Viola A, Manetti N Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study". Dig Liver Dis. 2017 Jan;49(1):17-23. doi: 10.1016/j.dld.2016.09.006. Epub 2016 Sep 21.
Borren NZ, Ananthakrishnan AN Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2019 Jan 4. pii: S1542-3565(19)30005-9. doi: 10.1016/j.cgh.2018.12.032.
Sturm A, Maaser C, Mendall M European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly. J Crohns Colitis. 2017 Mar 1;11(3):263-273. doi: 10.1093/ecco-jcc/jjw188. Epub 2016 Oct 20.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Anna Rycyk, Beata Kasztelan-Szczerbinska, Halina Cichoz-Lach
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 338
Number of citations: 0